Old Web
English
Sign In
Acemap
>
Paper
>
Asthma Outcomes in Pediatric Patients Utilizing XOLAIR (Omalizumab) in a Commercially Insured Population in the United States
Asthma Outcomes in Pediatric Patients Utilizing XOLAIR (Omalizumab) in a Commercially Insured Population in the United States
2021
P. Sullivan
Y. Ghaedsharaf
Z. Zheng
N. Mumneh
B. Ndife
Keywords:
Population
Omalizumab
Pediatrics
Asthma
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]